Related Experiment Video
Updated: Sep 2, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating
Yuling Li1,2, Jinfeng Qu2, Lu Liu1
1Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Abstract:
Apogossypolone (ApoG2), a novel derivative of gossypol lacking of two aldehyde groups, exhibits anti-tumor effects. However, the mechanisms by which ApoG2 regulates cervical cancer (CC) cells remain unclear. In this study, we treated two CC cell lines (CaSki and HeLa) with an increasing concentration of ApoG2 for 24 h. Cell Counting Kit-8 (CCK-8) assay, colony formation assay, flow cytometry and transwell invasion assay were utilized to detect cell proliferation, apoptosis and invasion in vitro. We first observed that ApoG2 inhibited cell proliferation, invasion and epithelial-to-mesenchymal transition (EMT) process in CC cells, along with upregulation of Dickkopf Wnt signaling pathway inhibitor 3 (DKK3) in a dose-dependent manner. The immunohistochemistry confirmed the downregulation of DKK3 in tumor tissues. Moreover, DKK3 was correlated with FIGO stage and lymph node metastasis. Functionally, DKK3 overexpression significantly suppressed cell viability, colony formation and invasion, but promoted apoptosis in CaSki and HeLa cells. Overexpression of DKK3 upregulated the protein levels of cleaved caspase-3 and E-cadherin, but downregulated the protein levels of Bcl-2, N-cadherin and Vimentin. Furthermore, DKK3 knockdown reversed the suppressive effects of ApoG2 on CaSki cell proliferation, invasion and EMT markers, while DKK3 overexpression enhanced these effects. In addition, ApoG2 treatment inhibited CC xenograft tumor growth and upregulated the protein levels of DKK3, cleaved caspase-3 and E-cadherin. In conclusions, these findings suggested that ApoG2 could effectively inhibit the growth and invasion of CC cells at least partly by activating DKK3.
Insights
Apogossypolone (ApoG2) inhibits cervical cancer (CC) cell growth and invasion. This novel drug activates Dickkopf Wnt signaling pathway inhibitor 3 (DKK3), a key mechanism in its anti-tumor effects.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cervical cancer (CC) remains a significant health concern.
- The precise mechanisms of novel anti-tumor agents like Apogossypolone (ApoG2) in CC are not fully understood.
- Gossypol derivatives, such as ApoG2, show promise in cancer therapy.
Purpose of the Study:
- To elucidate the mechanisms by which ApoG2 regulates cervical cancer (CC) cells.
- To investigate the role of Dickkopf Wnt signaling pathway inhibitor 3 (DKK3) in ApoG2's anti-cancer effects.
- To evaluate ApoG2's efficacy in preclinical CC models.
Main Methods:
- Treatment of CC cell lines (CaSki, HeLa) with ApoG2.
- Assays for cell proliferation (CCK-8), colony formation, apoptosis (flow cytometry), and invasion (Transwell).
- Immunohistochemistry to assess DKK3 expression in tumor tissues and xenografts.
Main Results:
- ApoG2 inhibited CC cell proliferation, invasion, and epithelial-to-mesenchymal transition (EMT).
- ApoG2 upregulated Dickkopf Wnt signaling pathway inhibitor 3 (DKK3) expression in a dose-dependent manner.
- DKK3 overexpression suppressed cell viability and invasion while promoting apoptosis; ApoG2's effects were mediated by DKK3.
Conclusions:
- Apogossypolone (ApoG2) demonstrates significant anti-tumor activity against cervical cancer cells.
- The activation of Dickkopf Wnt signaling pathway inhibitor 3 (DKK3) is a key mechanism underlying ApoG2's efficacy.
- ApoG2 holds potential as a therapeutic agent for cervical cancer, warranting further investigation.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Anaphase Promoting Complex
Abnormal Proliferation
Mitogens and the Cell Cycle
Cancer Cell Migration through Invadopodia

